The Economic Times
English EditionEnglish Editionहिंदी संस्करण
| 05 May, 2021, 08:42 AM IST | E-Paper
Search
+

    Two Indian vaccine shots aren’t yet enough for a vaccine passport

    Synopsis

    Of the two vaccines in use in India, only Covishield, manufactured by Serum Institute of India (SII) under licence from AstraZeneca, has WHO approval.

    Indian vaccine makers may face a new hurdle, as western countries move ahead with plans to issue “vaccine passports”, that would allow entry only to travellers who are fully vaccinated with specific approved vaccines. Earlier this week, the European Union (EU) said that it will allow travellers from countries with a “good epidemiological situation”, as well as travellers who have been fully vaccinated with vaccines approved by EU regulators. It
    Share This Article
    • GIFT ARTICLE
    • FONT SIZE
    • SAVE
    • PRINT
    • COMMENT

    Sign in to read the full article

    You’ve got this Prime Story as a Free Gift

    Special Offer on ET Prime

    Subscribe to ET Prime - Get Flat 20% Off

    View Plans

    Special Offer on ET Prime

    Subscribe to ET Prime - Get Flat 20% Off

    View Plans

    Special Offer on ET Prime

    Subscribe to ET Prime - Get Flat 20% Off

    View Plans

    Why ?

    • Sharp Insight-rich, Indepth stories across 20+ sectors

    • Access the exclusive Economic Times stories, Editorial and Expert opinion

    • Clean experience with
      Minimal Ads
    • Comment & Engage with ET Prime community
    • Exclusive invites to Virtual Events with Industry Leaders
    • A trusted team of Journalists & Analysts who can best filter signal from noise
    The Economic Times